129 related articles for article (PubMed ID: 17908177)
1. Amygdala protein kinase C epsilon regulates corticotropin-releasing factor and anxiety-like behavior.
Lesscher HM; McMahon T; Lasek AW; Chou WH; Connolly J; Kharazia V; Messing RO
Genes Brain Behav; 2008 Apr; 7(3):323-33. PubMed ID: 17908177
[TBL] [Abstract][Full Text] [Related]
2. Protein kinase C epsilon mediation of CRF- and ethanol-induced GABA release in central amygdala.
Bajo M; Cruz MT; Siggins GR; Messing R; Roberto M
Proc Natl Acad Sci U S A; 2008 Jun; 105(24):8410-5. PubMed ID: 18541912
[TBL] [Abstract][Full Text] [Related]
3. Tissue plasminogen activator promotes the effects of corticotropin-releasing factor on the amygdala and anxiety-like behavior.
Matys T; Pawlak R; Matys E; Pavlides C; McEwen BS; Strickland S
Proc Natl Acad Sci U S A; 2004 Nov; 101(46):16345-50. PubMed ID: 15522965
[TBL] [Abstract][Full Text] [Related]
4. Amygdala protein kinase C epsilon controls alcohol consumption.
Lesscher HM; Wallace MJ; Zeng L; Wang V; Deitchman JK; McMahon T; Messing RO; Newton PM
Genes Brain Behav; 2009 Jul; 8(5):493-9. PubMed ID: 19243450
[TBL] [Abstract][Full Text] [Related]
5. Prolonged and site-specific over-expression of corticotropin-releasing factor reveals differential roles for extended amygdala nuclei in emotional regulation.
Regev L; Neufeld-Cohen A; Tsoory M; Kuperman Y; Getselter D; Gil S; Chen A
Mol Psychiatry; 2011 Jul; 16(7):714-28. PubMed ID: 20548294
[TBL] [Abstract][Full Text] [Related]
6. Local repeated corticotropin-releasing factor infusion exacerbates anxiety- and fear-related behavior: differential involvement of the basolateral amygdala and medial prefrontal cortex.
Bijlsma EY; van Leeuwen ML; Westphal KG; Olivier B; Groenink L
Neuroscience; 2011 Jan; 173():82-92. PubMed ID: 21093544
[TBL] [Abstract][Full Text] [Related]
7. Pro- and anti-nociceptive effects of corticotropin-releasing factor (CRF) in central amygdala neurons are mediated through different receptors.
Ji G; Neugebauer V
J Neurophysiol; 2008 Mar; 99(3):1201-12. PubMed ID: 18171711
[TBL] [Abstract][Full Text] [Related]
8. Cardioprotection mediated by urocortin is dependent on PKCepsilon activation.
Lawrence KM; Kabir AM; Bellahcene M; Davidson S; Cao XB; McCormick J; Mesquita RA; Carroll CJ; Chanalaris A; Townsend PA; Hubank M; Stephanou A; Knight RA; Marber MS; Latchman DS
FASEB J; 2005 May; 19(7):831-3. PubMed ID: 15764590
[TBL] [Abstract][Full Text] [Related]
9. Corticosterone delivery to the amygdala increases corticotropin-releasing factor mRNA in the central amygdaloid nucleus and anxiety-like behavior.
Shepard JD; Barron KW; Myers DA
Brain Res; 2000 Apr; 861(2):288-95. PubMed ID: 10760490
[TBL] [Abstract][Full Text] [Related]
10. CRF receptor type 1 (but not type 2) located within the amygdala plays a role in the modulation of anxiety in mice exposed to the elevated plus maze.
Cipriano AC; Gomes KS; Nunes-de-Souza RL
Horm Behav; 2016 May; 81():59-67. PubMed ID: 27060334
[TBL] [Abstract][Full Text] [Related]
11. Role of stress, corticotrophin releasing factor (CRF) and amygdala plasticity in chronic anxiety.
Shekhar A; Truitt W; Rainnie D; Sajdyk T
Stress; 2005 Dec; 8(4):209-19. PubMed ID: 16423710
[TBL] [Abstract][Full Text] [Related]
12. Chronic stimulation of corticotropin-releasing factor receptor 1 enhances the anxiogenic response of the cholecystokinin system.
Sherrin T; Todorovic C; Zeyda T; Tan CH; Wong PT; Zhu YZ; Spiess J
Mol Psychiatry; 2009 Mar; 14(3):291-307. PubMed ID: 18195718
[TBL] [Abstract][Full Text] [Related]
13. Site-specific genetic manipulation of amygdala corticotropin-releasing factor reveals its imperative role in mediating behavioral response to challenge.
Regev L; Tsoory M; Gil S; Chen A
Biol Psychiatry; 2012 Feb; 71(4):317-26. PubMed ID: 21783178
[TBL] [Abstract][Full Text] [Related]
14. Corticotropin-releasing factor and defensive withdrawal: inhibition of monoamine oxidase prevents habituation to chronic stress.
Ward HE; Johnson EA; Goodman IJ; Birkle DL; Cottrell DJ; Azzaro AJ
Pharmacol Biochem Behav; 1998 May; 60(1):209-15. PubMed ID: 9610944
[TBL] [Abstract][Full Text] [Related]
15. Extended Amygdala to Ventral Tegmental Area Corticotropin-Releasing Factor Circuit Controls Binge Ethanol Intake.
Rinker JA; Marshall SA; Mazzone CM; Lowery-Gionta EG; Gulati V; Pleil KE; Kash TL; Navarro M; Thiele TE
Biol Psychiatry; 2017 Jun; 81(11):930-940. PubMed ID: 27113502
[TBL] [Abstract][Full Text] [Related]
16. Brain-specific serine/threonine-protein kinase 1 is a substrate of protein kinase C epsilon involved in sex-specific ethanol and anxiety phenotypes.
Dugan MP; Maiya R; Fleischer C; Bajo M; Snyder AE; Koduri A; Srinivasan S; Roberto M; Messing RO
Addict Biol; 2024 Mar; 29(3):e13388. PubMed ID: 38497285
[TBL] [Abstract][Full Text] [Related]
17. Corticotropin-releasing factor gene expression is down-regulated in the central nucleus of the amygdala of alcohol-preferring rats which exhibit high anxiety: a comparison between rat lines selectively bred for high and low alcohol preference.
Hwang BH; Stewart R; Zhang JK; Lumeng L; Li TK
Brain Res; 2004 Nov; 1026(1):143-50. PubMed ID: 15476706
[TBL] [Abstract][Full Text] [Related]
18. Localization of the delta opioid receptor and corticotropin-releasing factor in the amygdalar complex: role in anxiety.
Reyes BAS; Kravets JL; Connelly KL; Unterwald EM; Van Bockstaele EJ
Brain Struct Funct; 2017 Mar; 222(2):1007-1026. PubMed ID: 27376372
[TBL] [Abstract][Full Text] [Related]
19. Regulation of corticotropin-releasing factor (CRF) messenger ribonucleic acid and CRF peptide in the amygdala: studies in primary amygdalar cultures.
Kasckow JW; Regmi A; Gill PS; Parkes DG; Geracioti TD
Endocrinology; 1997 Nov; 138(11):4774-82. PubMed ID: 9348205
[TBL] [Abstract][Full Text] [Related]
20. Neonatal thyroxine treatment: changes in the number of corticotropin-releasing-factor (CRF) and neuropeptide Y (NPY) containing neurons and density of tyrosine hydroxylase positive fibers (TH) in the amygdala correlate with anxiety-related behavior of wistar rats.
Yilmazer-Hanke DM; Hantsch M; Hanke J; Schulz C; Faber-Zuschratter H; Schwegler H
Neuroscience; 2004; 124(2):283-97. PubMed ID: 14980379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
